These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 35278410)

  • 1. Apolipoprotein A-V is a potential target for treating coronary artery disease: evidence from genetic and metabolomic analyses.
    Ibi D; Boot M; Dollé MET; Jukema JW; Rosendaal FR; Christodoulides C; Neville MJ; Koivula R; Rensen PCN; Karpe F; Noordam R; Willems van Dijk K
    J Lipid Res; 2022 May; 63(5):100193. PubMed ID: 35278410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Triglyceride-lowering LPL alleles combined with LDL-C-lowering alleles are associated with an additively improved lipoprotein profile.
    Ibi D; Blauw LL; Noordam R; Dollé MET; Jukema JW; Rosendaal FR; Christodoulides C; Neville MJ; Koivula R; Rensen PCN; Karpe F; van Dijk KW
    Atherosclerosis; 2021 Jul; 328():144-152. PubMed ID: 34053745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of causal effect of APOA5 variants on premature coronary artery disease.
    Wang F; Wang IZ; Ellis S; Archacki S; Barnard J; Hubbard C; Topol EJ; Chen Q; Wang QK
    Ann Hum Genet; 2018 Nov; 82(6):437-447. PubMed ID: 30024021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of apolipoprotein A5 concentration with serum insulin and triglyceride levels and coronary artery disease in Korean men.
    Hyun YJ; Jang Y; Chae JS; Kim JY; Paik JK; Kim SY; Yang JY; Ordovas JM; Ko YG; Lee JH
    Atherosclerosis; 2009 Aug; 205(2):568-73. PubMed ID: 19185864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The apolipoprotein A5 -1131T>C promoter polymorphism in Koreans: association with plasma APOA5 and serum triglyceride concentrations, LDL particle size and coronary artery disease.
    Jang Y; Paik JK; Hyun YJ; Chae JS; Kim JY; Choi JR; Lee SH; Shin DJ; Ordovas JM; Lee JH
    Clin Chim Acta; 2009 Apr; 402(1-2):83-7. PubMed ID: 19159622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The -1131 T>C and S19W APOA5 gene polymorphisms are associated with high levels of triglycerides and apolipoprotein C-III, but not with coronary artery disease: an angiographic study.
    Martinelli N; Trabetti E; Bassi A; Girelli D; Friso S; Pizzolo F; Sandri M; Malerba G; Pignatti PF; Corrocher R; Olivieri O
    Atherosclerosis; 2007 Apr; 191(2):409-17. PubMed ID: 16682041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A genetic variant c.553G > T (rs2075291) in the apolipoprotein A5 gene is associated with altered triglycerides levels in coronary artery disease (CAD) patients with lipid lowering drug.
    Bogari NM; Aljohani A; Amin AA; Al-Allaf FA; Dannoun A; Taher MM; Elsayed A; Rednah DI; Elkhatee O; Porqueddu M; Alamanni F; Khogeer SAA; Fawzy A
    BMC Cardiovasc Disord; 2019 Jan; 19(1):2. PubMed ID: 30606120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Genetically Enhanced Lipoprotein Lipase-Mediated Lipolysis and Low-Density Lipoprotein Cholesterol-Lowering Alleles With Risk of Coronary Disease and Type 2 Diabetes.
    Lotta LA; Stewart ID; Sharp SJ; Day FR; Burgess S; Luan J; Bowker N; Cai L; Li C; Wittemans LBL; Kerrison ND; Khaw KT; McCarthy MI; O'Rahilly S; Scott RA; Savage DB; Perry JRB; Langenberg C; Wareham NJ
    JAMA Cardiol; 2018 Oct; 3(10):957-966. PubMed ID: 30326043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Additive effects of LPL, APOA5 and APOE variant combinations on triglyceride levels and hypertriglyceridemia: results of the ICARIA genetic sub-study.
    Ariza MJ; Sánchez-Chaparro MA; Barón FJ; Hornos AM; Calvo-Bonacho E; Rioja J; Valdivielso P; Gelpi JA; González-Santos P
    BMC Med Genet; 2010 Apr; 11():66. PubMed ID: 20429872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Triglyceride-Lowering LPL Variants and LDL-C-Lowering LDLR Variants With Risk of Coronary Heart Disease.
    Ference BA; Kastelein JJP; Ray KK; Ginsberg HN; Chapman MJ; Packard CJ; Laufs U; Oliver-Williams C; Wood AM; Butterworth AS; Di Angelantonio E; Danesh J; Nicholls SJ; Bhatt DL; Sabatine MS; Catapano AL
    JAMA; 2019 Jan; 321(4):364-373. PubMed ID: 30694319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of apolipoprotein A-V on plasma triglyceride, lipoprotein size, and composition in genetically engineered mice.
    Nelbach L; Shu X; Konrad RJ; Ryan RO; Forte TM
    J Lipid Res; 2008 Mar; 49(3):572-80. PubMed ID: 18056685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New insights into apolipoprotein A5 in controlling lipoprotein metabolism in obesity and the metabolic syndrome patients.
    Su X; Kong Y; Peng DQ
    Lipids Health Dis; 2018 Jul; 17(1):174. PubMed ID: 30053818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A functional variant in APOA5/A4/C3/A1 gene cluster contributes to elevated triglycerides and severity of CAD by interfering with microRNA 3201 binding efficiency.
    Cui G; Li Z; Li R; Huang J; Wang H; Zhang L; Ding H; Wang DW
    J Am Coll Cardiol; 2014 Jul; 64(3):267-77. PubMed ID: 25034063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of polymorphisms in APOA5 on the plasma levels of triglycerides and risk of coronary heart disease in Jilin, northeast China: a case-control study.
    You Y; Wu YH; Zhang Y; Zhang L; Song Y; Bai W; Li Y; Yu Y; Kou C
    BMJ Open; 2018 Jun; 8(6):e020016. PubMed ID: 29866721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Arg282Ser missense mutation in APOA5 gene determines a reduction of triglyceride and LDL-cholesterol in children, together with low serum levels of apolipoprotein A-V.
    Bertoccini L; Sentinelli F; Incani M; Bailetti D; Cimini FA; Barchetta I; Cavallo MG; Cossu E; Lenzi A; Loche S; Baroni MG
    Lipids Health Dis; 2017 Sep; 16(1):179. PubMed ID: 28927406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Common variants in the genes of triglyceride and HDL-C metabolism lack association with coronary artery disease in the Pakistani subjects.
    Shahid SU; Shabana NA; Cooper JA; Rehman A; Humphries SE
    Lipids Health Dis; 2017 Jan; 16(1):24. PubMed ID: 28143480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A genetic variant c.553G > T in the apolipoprotein A5 gene is associated with an increased risk of coronary artery disease and altered triglyceride levels in a Chinese population.
    Tang Y; Sun P; Guo D; Ferro A; Ji Y; Chen Q; Fan L
    Atherosclerosis; 2006 Apr; 185(2):433-7. PubMed ID: 16046221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose-Response Associations of Lipid Traits With Coronary Artery Disease and Mortality.
    Yang G; Mason AM; Wood AM; Schooling CM; Burgess S
    JAMA Netw Open; 2024 Jan; 7(1):e2352572. PubMed ID: 38241044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutation screening of the APOA5 gene in subjects with coronary artery disease.
    Soufi M; Sattler AM; Kurt B; Schaefer JR
    J Investig Med; 2012 Oct; 60(7):1015-9. PubMed ID: 22914599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emerging evidences for the opposite role of apolipoprotein C3 and apolipoprotein A5 in lipid metabolism and coronary artery disease.
    Dai W; Zhang Z; Yao C; Zhao S
    Lipids Health Dis; 2019 Dec; 18(1):220. PubMed ID: 31836003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.